TrialHepatology international2023

Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion.

Chunmei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.